Zomelis
Healthcare
04 December, 2019
Eris Lifesciences buys anti-diabetic drug from Novartis for India market
Eris Lifesciences Ltd said it has acquired the trademark for anti-diabetic drug Zomelis for $13 million (Rs 92.9 crore) from ......
Most Popular
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News